UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9262) 9262
Patent (289) 289
Book Chapter (85) 85
Magazine Article (28) 28
Book / eBook (13) 13
Newsletter (11) 11
Conference Proceeding (9) 9
Dissertation (5) 5
Government Document (2) 2
Newspaper Article (2) 2
Web Resource (2) 2
Publication (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7526) 7526
science & technology (6666) 6666
life sciences & biomedicine (6388) 6388
female (3582) 3582
combined modality therapy (3390) 3390
male (3078) 3078
animals (2415) 2415
oncology (2311) 2311
immunology (2154) 2154
immunotherapy (1759) 1759
antineoplastic combined chemotherapy protocols - therapeutic use (1600) 1600
vaccines (1579) 1579
middle aged (1531) 1531
adult (1461) 1461
cancer (1454) 1454
infant (1370) 1370
vaccination (1369) 1369
treatment outcome (1354) 1354
mice (1300) 1300
aged (1200) 1200
chemotherapy (1066) 1066
care and treatment (1059) 1059
vaccines, combined - immunology (1008) 1008
child (995) 995
medicine, research & experimental (960) 960
research & experimental medicine (958) 958
vaccines, combined - administration & dosage (896) 896
abridged index medicus (891) 891
immunization (853) 853
child, preschool (831) 831
health aspects (820) 820
research (754) 754
antineoplastic agents - therapeutic use (731) 731
adolescent (719) 719
combined vaccines (710) 710
infectious diseases (687) 687
cancer vaccines - therapeutic use (680) 680
immunotherapy - methods (675) 675
antigens (672) 672
vaccines, combined - adverse effects (670) 670
prognosis (661) 661
medicine & public health (647) 647
clinical trials as topic (635) 635
tumors (630) 630
pediatrics (614) 614
immunization schedule (577) 577
analysis (572) 572
neoplasm staging (568) 568
clinical trials (565) 565
immune response (508) 508
lymphocytes (494) 494
vaccines, combined (490) 490
t cells (469) 469
neoplasms - therapy (462) 462
follow-up studies (458) 458
hematology (457) 457
cancer vaccines - immunology (456) 456
melanoma (448) 448
drug therapy (444) 444
cell line, tumor (437) 437
immune system (436) 436
metastasis (436) 436
bcg vaccine - therapeutic use (427) 427
medical research (426) 426
risk factors (424) 424
pharmacology & pharmacy (416) 416
lymphocytes t (415) 415
mice, inbred balb c (408) 408
time factors (406) 406
infections (400) 400
cancer therapies (399) 399
neoplasms - immunology (391) 391
aged, 80 and over (390) 390
proteins (389) 389
viruses (388) 388
allergy and immunology (387) 387
surgery (385) 385
biotechnology & applied microbiology (383) 383
mice, inbred c57bl (383) 383
medicine (373) 373
measles-mumps-rubella vaccine (372) 372
antibodies (371) 371
vaccine (369) 369
children (368) 368
severe combined immunodeficiency (365) 365
survival rate (364) 364
t-lymphocytes - immunology (363) 363
antineoplastic combined chemotherapy protocols - adverse effects (362) 362
immunogenicity (362) 362
general & internal medicine (359) 359
studies (355) 355
research article (350) 350
survival analysis (347) 347
medicine, general & internal (342) 342
infant, newborn (340) 340
antibodies, monoclonal - therapeutic use (338) 338
dendritic cells (334) 334
antibodies, viral - blood (330) 330
radiotherapy (327) 327
patients (326) 326
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9121) 9121
French (159) 159
Chinese (157) 157
Russian (155) 155
German (148) 148
Japanese (98) 98
Spanish (93) 93
Italian (47) 47
Portuguese (38) 38
Polish (28) 28
Dutch (14) 14
Korean (13) 13
Danish (11) 11
Hungarian (9) 9
Romanian (8) 8
Czech (7) 7
Bulgarian (5) 5
Swedish (4) 4
Norwegian (3) 3
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pediatrics, ISSN 0031-4005, 01/2009, Volume 123, Issue 1, pp. 301 - 312
Our goal was to compare the safety and immunogenicity of a combination vaccine (DTaP(5)-IPV-Hib; Pentacel) with that of its separately administered, US-licensed equivalent vaccines... 
Vaccines combined | Poliovirus vaccine inactivated | Diphtheria-tetanus-acellular pertussis vaccines | Haemophilus influenzae vaccines | Diphtheria-Tetanus-Pertussis Vaccine | Immunization, Secondary - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | United States | Humans | Vaccines, Conjugate - adverse effects | Child, Preschool | Infant | Male | Bacterial Vaccines - pharmacokinetics | Vaccines, Combined - administration & dosage | Antibodies, Viral - blood | Vaccines, Combined - pharmacokinetics | Antibodies, Bacterial - biosynthesis | Female | Immunization Schedule | Poliovirus Vaccine, Inactivated - pharmacokinetics | Diphtheria-Tetanus-acellular Pertussis Vaccines - adverse effects | Antibodies, Bacterial - blood | Child | Antibodies, Viral - biosynthesis | Vaccines, Conjugate - metabolism | Diphtheria-Tetanus-acellular Pertussis Vaccines - pharmacokinetics | Bacterial Vaccines - adverse effects | Immunization, Secondary - methods | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Bacterial Vaccines - administration & dosage | Haemophilus Vaccines | Poliovirus Vaccine, Inactivated - adverse effects | Diphtheria-Tetanus-acellular Pertussis Vaccines - administration & dosage | Therapeutic Equivalency | Pertussis vaccines | Viral antibodies | Demographic aspects | Hib vaccines | Antibodies | Physiological aspects | Dosage and administration | Research | Clinical trials | Pediatrics | Vaccines | Safety | Comparative analysis | Index Medicus | Abridged Index Medicus
Journal Article
Clinical and vaccine immunology, ISSN 1556-6811, 11/2009, Volume 17, Issue 1, pp. 154 - 159
Journal Article
Human vaccines, ISSN 1554-8600, 11/2011, Volume 7, Issue 11, pp. 1137 - 1145
The immunogenicity and safety of the 10-valent pneumococcal conjugate vaccine, PHiD-CV, have been documented in European and Asian studies... 
safety | immunogenicity | pneumococcal vaccine | Nontypeable Haemophilus influenzae | Safety | Immunogenicity | Pneumococcal vaccine | Streptococcus pneumoniae | Immunology | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Streptococcus pneumoniae - classification | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccines, Conjugate - adverse effects | Haemophilus Infections - prevention & control | Infant | Male | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Poliovirus Vaccine, Inactivated - immunology | Immunoglobulin D - immunology | Streptococcus pneumoniae - immunology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Pneumococcal Infections - immunology | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Rotavirus Vaccines - adverse effects | Female | Immunization Schedule | Bacterial Proteins - immunology | Pneumococcal Vaccines - adverse effects | Antibodies, Bacterial - blood | Carrier Proteins - immunology | Rotavirus Vaccines - administration & dosage | Serotyping | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Rotavirus Vaccines - immunology | Hepatitis B Vaccines - administration & dosage | Opsonin Proteins - metabolism | Treatment Outcome | Haemophilus Vaccines - immunology | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Haemophilus influenzae - immunology | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Poliovirus Vaccine, Inactivated - adverse effects | Mexico | Hepatitis B Vaccines - immunology | Haemophilus Infections - immunology | Lipoproteins - immunology | Phagocytosis | Index Medicus
Journal Article
Clinical and vaccine immunology, ISSN 1556-679X, 01/2014, Volume 21, Issue 1, pp. 56 - 65
Journal Article
Journal Article
Archives of virology, ISSN 0304-8608, 3/2018, Volume 163, Issue 3, pp. 587 - 597
To be effective, therapeutic cancer vaccines should stimulate both an effective cell-mediated and a robust cytotoxic CD8... 
Medical Microbiology | Infectious Diseases | Biomedicine | Virology | Life Sciences & Biomedicine | Science & Technology | Vaccines, DNA - genetics | Adjuvants, Immunologic - administration & dosage | Papillomavirus Vaccines - genetics | Epithelial Cells - drug effects | Tumor Necrosis Factor-alpha - genetics | Vaccination | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Human papillomavirus 16 - drug effects | Human papillomavirus 16 - immunology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | Vaccines, DNA - administration & dosage | Melatonin - administration & dosage | Papillomavirus E7 Proteins - genetics | Cancer Vaccines - genetics | T-Lymphocytes, Cytotoxic - drug effects | Tumor Necrosis Factor-alpha - immunology | Melatonin - immunology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Interferon-gamma - genetics | Interleukin-4 - genetics | Papillomavirus Vaccines - administration & dosage | T-Lymphocytes, Cytotoxic - immunology | Cancer Vaccines - administration & dosage | Mice, Inbred C57BL | Plasmids - immunology | Gene Expression Regulation | Vascular Endothelial Growth Factor A - immunology | Papillomavirus Infections - mortality | Tumor Burden | Cancer Vaccines - immunology | Interleukin-4 - immunology | Animals | Lymphocyte Activation - drug effects | Papillomavirus Infections - prevention & control | Epithelial Cells - immunology | Interferon-gamma - immunology | Plasmids - chemistry | Survival Analysis | Cell Line, Tumor | Papillomavirus Vaccines - immunology | Cell Proliferation - drug effects | Mice | Human papillomavirus 16 - genetics | Plasmids - administration & dosage | Melatonin | Endothelial growth factors | Analysis | DNA | Resveratrol | Genetic research | Vaccines | T cells | Health aspects | Papillomavirus infections | Cell proliferation | Cell survival | CD8 antigen | Cytotoxicity | Lymphocytes T | DNA vaccines | Tumor necrosis factor-α | Cancer vaccines | Human papillomavirus | Interleukin 4 | γ-Interferon | Combined vaccines | Interleukin 10 | Antitumor activity | Interferon | Lactic acid | Vascular endothelial growth factor | Enzyme-linked immunosorbent assay | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
Journal Article
Infection and Immunity, ISSN 0019-9567, 12/2007, Volume 75, Issue 12, pp. 5819 - 5826
Journal Article
Journal Article